Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Junshi Biosciences has received acceptance from China’sNational Medical Products Administration (NMPA) for toripalimab ...
Subcutaneous immunotherapy for cancer can cause many of the same side effects as intravenous (IV) immunotherapy because it involves the same medications. Injection site reactions are a common but ...
USD 8.7 Billion; 2032 Projected Market Size: USD 11.9 Billion; CAGR (2025–2032): 4.57%; Heparin Market forecast accounts for ...
ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean ...
Rhythm Pharma (RYTM) surges on IMCIVREE sales growth and TRANSCEND data ahead of the March 20 FDA PDUFA decision—see risks, ...
Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...
Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy ...
One experimental injection helped mice and pigs heal after heart attack by boosting a protective heart hormone. (CREDIT: ...
Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results